Form 4 holding
Director
Oric Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 28,000
- Estimated value
- $264,040
- Report date
- 23 Jun 2025
- Price
- $9.43
- Ownership
- Direct
Angie You
Insider Reports History
- Location
- South San Francisco, CA
- Signature
- /s/ Christian Kuhlen, attorney-in-fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Angie You:
Form 4 holding
Director
Oric Pharmaceuticals, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 40,000
- Estimated value
- Report date
- 02 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
RayzeBio, Inc.
- Security class
- Employee Stock Option (right to buy)
- Shares / value
- 0
- Estimated value
- Report date
- 26 Feb 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Angie You
4
ORIC
Oric Pharmaceuticals, Inc.
- Report period
- 02 Jan 2026
- Transactions
- 1
- Transaction value
- $0
- Filing time
- 06 Jan 2026, 16:49
- Role
- Director
- Next action
- Open filing details
4
ORIC
Oric Pharmaceuticals, Inc.
- Report period
- 20 Jun 2025
- Transactions
- 2
- Transaction value
- +$262,899
- Filing time
- 23 Jun 2025, 20:05
- Role
- Director
- Next action
- Open filing details
4
ORIC
Oric Pharmaceuticals, Inc.
- Report period
- 02 Jan 2025
- Transactions
- 1
- Transaction value
- $0
- Filing time
- 06 Jan 2025, 16:47
- Role
- Director
- Next action
- Open filing details
4
ORIC
Oric Pharmaceuticals, Inc.
- Report period
- 12 Jun 2024
- Transactions
- 1
- Transaction value
- $0
- Filing time
- 14 Jun 2024, 16:26
- Role
- Director
- Next action
- Open filing details
4
RayzeBio, Inc.
- Report period
- 26 Feb 2024
- Transactions
- 2
- Transaction value
- $0
- Filing time
- 27 Feb 2024, 17:10
- Role
- Director
- Next action
- Open filing details
3
RayzeBio, Inc.
- Report period
- 14 Sep 2023
- Transactions
- 0
- Transaction value
- $0
- Filing time
- 14 Sep 2023, 19:32
- Role
- Director
- Next action
- Open filing details
4
ORIC
Oric Pharmaceuticals, Inc.
- Report period
- 14 Jun 2023
- Transactions
- 1
- Transaction value
- $0
- Filing time
- 15 Jun 2023, 16:58
- Role
- Director
- Next action
- Open filing details
4
ORIC
Oric Pharmaceuticals, Inc.
- Report period
- 17 Jun 2022
- Transactions
- 1
- Transaction value
- $0
- Filing time
- 17 Jun 2022, 20:25
- Role
- Director
- Next action
- Open filing details
4
ORIC
Oric Pharmaceuticals, Inc.
- Report period
- 09 Nov 2021
- Transactions
- 1
- Transaction value
- $0
- Filing time
- 10 Nov 2021, 16:53
- Role
- Director
- Next action
- Open filing details
3
ORIC
Oric Pharmaceuticals, Inc.
- Report period
- 09 Nov 2021
- Transactions
- 0
- Transaction value
- $0
- Filing time
- 10 Nov 2021, 16:51
- Role
- Director
- Next action
- Open filing details